AOD-9604 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability. AOD-9604 is not fda-approved. development discontinued 2007. available as research chemical. As with any research compound, individual responses vary.
Is AOD-9604 Safe?
Safety is the most important consideration with any research compound. AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog with a safety profile established through preclinical research.
12-week RCT showed 2.6 kg weight loss vs 0.8 kg placebo. However, a larger 24-week Phase III trial (536 subjects) failed to demonstrate significant weight loss, leading to development discontinuation in 2007. Six controlled trials established tolerability across 900+ subjects.
What Are the Known Side Effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
These effects are based on preclinical data and community reports at standard dosages of 250-1000 mcg daily. Higher doses generally increase both the likelihood and severity of side effects.
Are AOD-9604 Side Effects Dose-Dependent?
Most reported AOD-9604 side effects are dose-dependent — meaning they're more likely at higher doses and less likely at the lower end of the 250-1000 mcg daily range.
This is why starting at the minimum effective dose and titrating up is the standard approach. With a half-life of not established, any adverse effects will typically resolve within a few half-life periods after discontinuation.
What About Long-Term AOD-9604 Use?
Long-term safety data for AOD-9604 is limited, as with most research peptides. Standard cycles run 12-24 weeks.
AOD-9604 is not fda-approved. development discontinued 2007. available as research chemical. Extended use beyond recommended cycles should be approached with caution.
Does AOD-9604 Interact With Other Compounds?
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols.
When stacking peptides, be aware that combining multiple compounds increases the total side-effect surface area. Monitor closely when introducing any new compound.
How Can You Minimize AOD-9604 Side Effects?
Start at the lower end of the dosage range (250-1000 mcg daily). Use proper reconstitution and injection technique to minimize injection site reactions. Store correctly (lyophilized at -20°C, reconstituted at 2-8°C) to maintain purity.
Source only from vendors with third-party COA testing — contaminated or mislabeled products are a significant source of unexpected adverse effects.
What Is the Bottom Line on AOD-9604 Safety?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability. Overall, AOD-9604 is considered well-tolerated at standard research doses.
Read our AOD-9604 dosage guide for protocols designed to minimize risk.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Related Reading
- AOD-9604 Dosage Guide
- AOD-9604 Benefits
- AOD-9604 Stacking Guide
- AOD-9604 Cycle Guide
- AOD-9604 Research
- CJC-1295 Complete Guide
Calculate Your AOD-9604 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for AOD-9604.
Open Calculator →Research-Grade Sourcing
If you're going to research AOD-9604, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Cycle length: 12-24 weeks. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 safe?
AOD-9604 has shown a favorable safety profile in research. Not FDA-approved. Development discontinued 2007. Available as research chemical. All research should follow appropriate safety protocols.